Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients: An Underrecognized Public Health Problem
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Experimental studies have shown that administration of nonsteroidal anti-inflammatory drugs (NSAIDs) to susceptible individuals can lead to the development of congestive heart failure (CHF). There have been few epidemiological investigations of the importance of this adverse effect. OBJECTIVE: To estimate the relative risk of first admission to a hospital with CHF in recent users of NSAIDs, compared with nonusers, and to determine whether the estimated relative risk was increased in those with a history of heart disease and the extent to which the level of risk varied with the dose and half-life of the drugs consumed. METHODS: We conducted a matched case-control study of the relationship between recent use of NSAIDs and hospitalization with CHF. Cases (n = 365) were patients admitted to hospitals with a primary diagnosis of CHF. Controls (n = 658) were patients without CHF who were admitted to the same hospitals as case patients. Structured interviews were used to obtain information on several study factors, including recent use of aspirin and other NSAIDs. RESULTS: Use of NSAIDs (other than low-dose aspirin) in the previous week was associated with a doubling of the odds of a hospital admission with CHF (adjusted odds ratio, 2.1; 95% confidence interval, 1.2-3.3). Use of NSAIDs by patients with a history of heart disease was associated with an odds ratio of 10.5 (95% confidence interval, 2.5-44.9) for first admission with heart failure, compared with 1.6 (95% confidence interval, 0.7-3.7) in those without such a history. The odds of a first admission to a hospital with CHF was positively related to the dose of NSAID consumed in the previous week, and was increased to a greater extent with long half-life than with short half-life drugs. Assuming these relationships are causal, NSAIDs were responsible for approximately 19% of hospital admissions with CHF. CONCLUSIONS: The burden of illness resulting from NSAID-related CHF may exceed that resulting from gastrointestinal tract damage. NSAIDs should be used with caution in patients with a history of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Case-Control Studies: Design, Conduct, Analysis.
Youkeles, L., & Schlesselman, J. J. (1983) · Journal of the American Statistical Association · doi:10.2307/2288156 · Cited by 2,346
Collett, D. (1991) · Springer eBooks · doi:10.1007/978-1-4899-4475-7 · Cited by 1,936
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Estimating the population attributable risk for multiple risk factors using case-control data.
BRUZZI, P., GREEN, S. B., BYAR, D. P., BRINTON, L. A., & SCHAIRER, C. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114174 · Cited by 1,214
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
Clive, D. M., & Stoff, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403013100905 · Cited by 1,122
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
Oates, J. A., Wood, A. J. J., Brooks, P. M., & Day, R. O. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242407 · Cited by 775
Dzau, V. J., Packer, M., Lilly, L. S., Swartz, S. L., Hollenberg, N. K., & Williams, G. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100603 · Cited by 428
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
Epidemiology and risk profile of heart failure
Bui, A. L., Horwich, T. B., & Fonarow, G. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.165 · Cited by 2,077
“therapies for chronic conditions may be limited when treatments that are beneficial in one condition are detrimental in another; for example, β-blockers in the presence of lung disease, ACE inhibitors in the presence of kidney disease, or nonsteroidal anti-inflammatory drugs for arthritis are contraindicated in HF”
BackgroundJessup, M., & Brozena, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021498 · Cited by 1,564
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018) · Aging and disease · doi:10.14336/ad.2017.0306 · Cited by 917
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
Use of NSAIDs in treating patients with arthritis
Crofford, L. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4174 · Cited by 650
The Potential Benefits of Red Beetroot Supplementation in Health and Disease
Clifford, T., Howatson, G., West, D., & Stevenson, E. (2015) · Nutrients · doi:10.3390/nu7042801 · Cited by 635
“However, these drugs, particularly in chronic doses, may actually have deleterious consequences for health and evoke negative side effects [74,76].”
BackgroundSchocken, D. D., Benjamin, E. J., Fonarow, G. C., Krumholz, H. M., Levy, D., Mensah, G. A., Narula, J., Shor, E. S., Young, J. B., & Hong, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.188965 · Cited by 552
Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
Weder, J. E., Dillon, C. T., Hambley, T. W., Kennedy, B. J., Lay, P. A., Biffin, J. R., Regtop, H. L., & Davies, N. M. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00086-3 · Cited by 536
The risk of congestive heart failure in rheumatoid arthritis: A population‐based study over 46 years
Nicola, P. J., Maradit‐Kremers, H., Roger, V. L., Jacobsen, S. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20855 · Cited by 483
Page, R. L., O’Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. (2016) · Circulation · doi:10.1161/cir.0000000000000426 · Cited by 471
Mamdani, M., Juurlink, D. N., Lee, D. S., Rochon, P. A., Kopp, A., Naglie, G., Austin, P. C., Laupacis, A., & Stukel, T. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16299-5 · Cited by 435
Atherton, J. J., Sindone, A., De Pasquale, C. G., Driscoll, A., MacDonald, P. S., Hopper, I., Kistler, P. M., Briffa, T., Wong, J., Abhayaratna, W., et al. (2018) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2018.06.1042 · Cited by 431
Ott, E., Nussmeier, N. A., Duke, P. C., Feneck, R. O., Alston, R. P., Snabes, M. C., Hubbard, R. C., Hsu, P. H., Saidman, L. J., & Mangano, D. T. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00125-9 · Cited by 403
Palliative Care in Congestive Heart Failure
Goodlin, S. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.078 · Cited by 370
Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
Vonkeman, H. E., & van de Laar, M. A. F. J. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.001 · Cited by 365
Whelton, A., Fort, J. G., Puma, J. A., Normandin, D., Bello, A. E., & Verburg, K. M. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200103000-00003 · Cited by 334
Ray, W. A., Stein, C. M., Hall, K., Daugherty, J. R., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07370-1 · Cited by 326
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Symptom burden in heart failure: assessment, impact on outcomes, and management
Alpert, C. M., Smith, M. A., Hummel, S. L., & Hummel, E. K. (2017) · Heart Failure Reviews · doi:10.1007/s10741-016-9581-4 · Cited by 304
Trends in the use of aspirin and nonsteroidal anti‐inflammatory drugs in the general U.S. population
Zhou, Y., Boudreau, D. M., & Freedman, A. N. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3463 · Cited by 304
Overview of Persistent Pain in Older Adults
Molton, I. R., & Terrill, A. L. (2014) · American Psychologist · doi:10.1037/a0035794 · Cited by 269
“For example, in older adults, long-term use of nonsteroidal anti-inflammatory drugs such as Ibuprofen is associated with gastrointestinal bleeding and renal dysfunction (Cooper & Burfield, 2010) and may exacerbate the development of congestive heart failure (Page & Henry, 2000).”
Renal Effects of COX-2-Selective Inhibitors
Brater, D. C., Harris, C., Redfern, J. S., & Gertz, B. J. (2001) · American Journal of Nephrology · doi:10.1159/000046212 · Cited by 265
Romero, L. M., & Remage-Healey, L. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7491 · Cited by 259
Castaño, A., Drachman, B. M., Judge, D., & Maurer, M. S. (2015) · Heart Failure Reviews · doi:10.1007/s10741-014-9462-7 · Cited by 254
Moore, R. A., Derry, S., Makinson, G. T., & McQuay, H. J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1704 · Cited by 223
“There are no known benefits for cyclooxygenase-2 selective inhibitors over nonspecific inhibitors relating to cardiac or renal function, and the known associations between NSAID use and renal failure [8] and heart failure [10,11] are likely to apply to cyclooxygenase-2 selective inhibitors.”
BackgroundFeenstra, J., Heerdink, E. R., Grobbee, D. E., & Stricker, B. H. C. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.265 · Cited by 194
Nicola, P. J., Crowson, C. S., Maradit‐Kremers, H., Ballman, K. V., Roger, V. L., Jacobsen, S. J., & Gabriel, S. E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21560 · Cited by 189
“Pericardial and valvular disease, which are possible complications of RA (35), and the potential cardiotoxic effect of RA drugs such as nonsteroidal antiinflammatory drugs (36,37), corticosteroids, chloroquine (38,39), D-penicillamine (40), or biologic agents (especially tumor necrosis factor inhibitors) may also play…”
BackgroundCardiovascular drug therapy in the elderly: benefits and challenges
Fleg, J. L., Aronow, W. S., & Frishman, W. H. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.162 · Cited by 186
The association between congestive heart failure and chronic renal disease
Silverberg, D., Wexler, D., Blum, M., Schwartz, D., & Iaina, A. (2004) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200403000-00004 · Cited by 177
Demographics and concomitant disorders in heart failure
Krum, H., & Gilbert, R. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13869-x · Cited by 159
Perazella, M. A., & Tray, K. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00757-4 · Cited by 158
Economic burden of chronic pain
Phillips, C. J. (2006) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.6.5.591 · Cited by 139
Co-morbidity in rheumatoid arthritis
Mikuls, T. R. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/s1521-6942(03)00041-x · Cited by 122
Whelton, A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.017 · Cited by 29
Metadata
- Authors
- Page, J., & Henry, D.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-03-27
- Volume
- 160
- Issue
- 6
- Pages
- 777
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2160950772
- Cited by
- 517
- References
- 16
- FWCI
- 26.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.